Jasper Therapeutics, Inc. (NASDAQ:JSPRW – Get Free Report) was the target of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 3,800 shares, a drop of 19.1% from the April 30th total of 4,700 shares. Based on an average daily trading volume, of 21,900 […]
Jasper Therapeutics, Inc. (NASDAQ:JSPRW – Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 3,800 shares, a drop of 19.1% from the April 30th total of 4,700 shares. Based on an average daily trading volume, of 21,900 […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine research firms that are currently covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock in the last […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued ratings on the stock in the last year […]
HC Wainwright reiterated their buy rating on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a report published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $65.00 price target on the stock. JSPR has been the subject of several other reports. Royal Bank of Canada began coverage on Jasper Therapeutics in a […]